Technical Analysis for RXRX - Recursion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 7.60 0.46% 0.03
RXRX closed down 2.82 percent on Tuesday, April 16, 2024, on 56 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 6
*** please verify all earnings dates ***
7 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.46%
Narrow Range Bar Range Contraction 0.46%
Wide Bands Range Expansion 0.46%
Down 3 Days in a Row Weakness 0.46%
Gapped Down Weakness 0.46%
Oversold Stochastic Weakness 0.46%
Expansion Breakdown Bearish Swing Setup -2.38%
Wide Bands Range Expansion -2.38%
Oversold Stochastic Weakness -2.38%
180 Bearish Setup Bearish Swing Setup -9.58%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 2 hours ago
Down 1% about 2 hours ago
Up 1% about 2 hours ago
Possible NR7 about 22 hours ago
Down 3% 1 day ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. It has four clinical-stage drug candidates focused on rare, monogenic diseases; and 33 additional programs in various stages of preclinical development. Recursion Pharmaceuticals, Inc. has strategic agreements with Bayer; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. The company was founded in 2013 and is based in Salt Lake City, Utah.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Health Sciences Health Care Drug Discovery Pharmaceutical Sciences Monogenic Diseases Rare

Is RXRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.745
52 Week Low 4.54
Average Volume 6,849,553
200-Day Moving Average 9.34
50-Day Moving Average 10.78
20-Day Moving Average 9.40
10-Day Moving Average 8.59
Average True Range 0.68
RSI (14) 30.07
ADX 16.25
+DI 17.41
-DI 33.42
Chandelier Exit (Long, 3 ATRs) 10.29
Chandelier Exit (Short, 3 ATRs) 9.56
Upper Bollinger Bands 11.39
Lower Bollinger Band 7.41
Percent B (%b) 0.04
BandWidth 42.38
MACD Line -0.81
MACD Signal Line -0.69
MACD Histogram -0.1265
Fundamentals Value
Market Cap 1.58 Billion
Num Shares 208 Million
EPS -1.46
Price-to-Earnings (P/E) Ratio -5.18
Price-to-Sales 49.87
Price-to-Book 4.88
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.96
Resistance 3 (R3) 7.98 7.88 7.90
Resistance 2 (R2) 7.88 7.78 7.87 7.87
Resistance 1 (R1) 7.72 7.72 7.67 7.70 7.85
Pivot Point 7.62 7.62 7.59 7.61 7.62
Support 1 (S1) 7.46 7.52 7.41 7.44 7.29
Support 2 (S2) 7.36 7.46 7.35 7.27
Support 3 (S3) 7.20 7.36 7.25
Support 4 (S4) 7.18